AnalystsThomas StephanThomas Stephan's Stock Forecasts
AnalystsThomas Stephan
Sectors:
Analyst Ranking
Top 24%
#1090 out of 4563 analysts
Average Return
+13.1%
Win Rate
69%11 out of 16
Risk vs Reward
Poor
Good
Thomas Stephan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sight Sciences IncSGHT | +66.27% | $3.38 | $5.62 | 2023-09-17 - 2024-04-24 | Strong Buy |
Glaukos CorpGKOS | +47.11% | $48.42 | $71.23 | 2022-07-11 - 2023-07-11 | Strong Buy |
Glaukos CorpGKOS | +46.72% | $68.79 | $100.93 | 2023-06-25 - 2024-04-24 | Strong Buy |
Rxsight IncRXST | +40.79% | $37.53 | $52.84 | 2023-12-11 - 2024-04-24 | Strong Buy |
Glaukos CorpGKOS | +33.75% | $75.46 | $100.93 | 2023-09-25 - 2024-04-24 | Strong Buy |
Thomas Stephan Analyst Color
Get additional color on Thomas Stephan's coverage of popular stocks
Thomas Stephan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alcon IncALC | 3 | Strong Buy | $95.00 | +19.39% | Maintains | 3 days ago |
Glaukos CorpGKOS | 4 | Strong Buy | $110.00 | +8.99% | Reiterates | 22 days ago |
Staar Surgical CoSTAA | 7 | Strong Buy | $50.00 | +4.56% | Maintains | 24 days ago |
Sight Sciences IncSGHT | 5 | Strong Buy | $7.00 | +24.56% | Maintains | 2 months ago |
Rxsight IncRXST | 3 | Strong Buy | $64.00 | +21.12% | Maintains | 2 months ago |
Bausch & Lomb CorpBLCO | 1 | Hold | $16.00 | +7.38% | Initiates Coverage On | 4 months ago |
Iridex CorpIRIX | 1 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.